XIENCE Safety Differentiators
XIENCE Stent Design: Low Stent Thrombosis Rates
A universal aim in the industry is to minimize the incidence of stent thrombosis (ST). XIENCE can point to extremely low stent thrombosis rates, even among complex patient populations.
The XIENCE coating technology is a key factor in minimizing stent thrombosis.
Protecting Patients from Stent Thrombosis
XIENCE VS OTHER DRUG-ELUTING STENTS
At rates of 0.0% and 0.1%, XIENCE outperforms other drug-eluting stents (DES) for 30-day stent thrombosis rates in these studies:
- The Resolute All Comers trial was designed to be representative of everyday clinical practice.6
- The Platinum Plus trial examined the XIENCE and Promus Element stents.7
Protecting Complex Patients
XIENCE VS BARE METAL STENTS
Compared to bare metal stents (BMS) in a meta-analysis of all-comer complex patients, XIENCE was shown to save lives.